MetaADEDB 2.0 @ LMMD
Acitretin
(IHUNBGSDBOWDMA-AQFIFDHZSA-N)
Structure
SMILES
COc1cc(C)c(c(c1C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C
Type(s)
Approved
ATC code(s)
D05BB02
Molecular Formula:
C21H26O3
Molecular Weight:
326.429
Log P:
5.1670
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
46.53
CAS Number(s):
54757-46-9; 55079-83-9; 69427-46-9
Synonym(s)
1.
Acitretin
2.
13-cis-Acitretin
3.
Etretin
4.
Isoetretin
5.
Acitretin, (Z,E,E,E)-Isomer
6.
Isoacitretin
7.
Neotigason
8.
Ro 10-1670
9.
Ro 13-7652
10.
Ro-10-1670
11.
Ro-13-7652
12.
Soriatane
13.
Ro 101670
14.
Ro 137652
15.
Ro101670
16.
Ro137652
External Link(s)
MeSHD017255
PubChem Compound5284513
BindingDB50088429
ChEBI50173
50172
CHEMBLCHEMBL1131
DrugBankDB00459
DrugCentral78
IUPHAR/BPS Guide to PHARMACOLOGY7598
KEGGdr:D02754
Therapeutic Target DatabaseD05QDC
ZINC3798734
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PregnancyFAERS: 102US FAERS
2Drug exposure during pregnancyFAERS: 100OFFSIDES
US FAERS
3AlopeciaFAERS: 57
Canada Vigilance: 5
Canada Vigilance
OFFSIDES
SIDER
US FAERS
4Drug ineffectiveFAERS: 54
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
5Transmission of drug via semenFAERS: 37OFFSIDES
US FAERS
6PsoriasisFAERS: 35

View details

CTD
OFFSIDES
SIDER
US FAERS
7Pregnancy of partnerFAERS: 32OFFSIDES
US FAERS
8PruritusFAERS: 31
Canada Vigilance: 1
11922592CTD
SIDER
Canada Vigilance
US FAERS
9Drug dose omissionFAERS: 30US FAERS
10HeadacheFAERS: 29
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
11Drug exposure before pregnancyFAERS: 27OFFSIDES
US FAERS
12PainFAERS: 24
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13ArthralgiaFAERS: 23
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
14MalaiseFAERS: 23
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
15Product use in unapproved indicationFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
16ErythemaFAERS: 19OFFSIDES
SIDER
US FAERS
17Drug administration errorFAERS: 16OFFSIDES
US FAERS
18Therapeutic response unexpectedFAERS: 16OFFSIDES
US FAERS
19Dry skinFAERS: 14
Canada Vigilance: 4
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20No adverse effectFAERS: 14OFFSIDES
US FAERS
21EpistaxisFAERS: 13
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
22Live BirthFAERS: 13OFFSIDES
US FAERS
23MyalgiaFAERS: 13SIDER
US FAERS
24Squamous cell carcinomaFAERS: 13US FAERS
25Alanine Aminotransferase IncreasedFAERS: 12
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
26Blood triglycerides increasedFAERS: 12OFFSIDES
SIDER
US FAERS
27OnychoclasisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
28Back PainFAERS: 11SIDER
US FAERS
29Cerebrovascular accidentFAERS: 11SIDER
US FAERS
30Aspartate Aminotransferase IncreasedFAERS: 10US FAERS
31FatigueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
32Maternal exposure before pregnancyFAERS: 9US FAERS
33PneumoniaFAERS: 9US FAERS
34Product dose omissionFAERS: 9US FAERS
35VomitingFAERS: 9SIDER
US FAERS
36Basal cell carcinomaFAERS: 8US FAERS
37Blood cholesterol increasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Blood creatinine increasedFAERS: 8SIDER
US FAERS
39Drug prescribing errorFAERS: 8US FAERS
40InfectionFAERS: 8SIDER
US FAERS
41Intentional product use issueFAERS: 8US FAERS
42Product use issueFAERS: 8US FAERS
43Skin UlcerFAERS: 8SIDER
US FAERS
44AnxietyFAERS: 7SIDER
US FAERS
45Diabetes MellitusFAERS: 7SIDER
US FAERS
46Exposure via fatherFAERS: 7US FAERS
47NasopharyngitisFAERS: 7US FAERS
48NauseaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
49NeutropeniaFAERS: 7US FAERS
50Weight decreasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
51Abdominal PainFAERS: 6SIDER
US FAERS
52ArthritisFAERS: 6SIDER
US FAERS
53Bowen's DiseaseFAERS: 6US FAERS
54Drug effect incompleteFAERS: 6US FAERS
55Lip exfoliationFAERS: 6OFFSIDES
US FAERS
56Medication ErrorFAERS: 6US FAERS
57Myocardial InfarctionFAERS: 6US FAERS
58PancreatitisFAERS: 6
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
59Pyogenic granulomaFAERS: 6OFFSIDES
SIDER
US FAERS
60Atrial FibrillationFAERS: 5US FAERS
61Blood lactate dehydrogenase increasedFAERS: 5OFFSIDES
US FAERS
62Drug dispensing errorFAERS: 5OFFSIDES
US FAERS
63Erectile dysfunctionFAERS: 5SIDER
US FAERS
64HyperthyroidismFAERS: 5US FAERS
65Inability to afford medicationFAERS: 5US FAERS
66Incorrect dose administeredFAERS: 5US FAERS
67Joint swellingFAERS: 5US FAERS
68Musculoskeletal stiffnessFAERS: 5
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
69OsteoporosisFAERS: 5OFFSIDES
US FAERS
70Pain of skinFAERS: 5OFFSIDES
US FAERS
71Product supply issueFAERS: 5US FAERS
72Pulmonary EmbolismFAERS: 5US FAERS
73Skin ErosionFAERS: 5US FAERS
74Skin lesionFAERS: 5US FAERS
75UrticariaFAERS: 5SIDER
US FAERS
76Acute promyelocytic leukaemia differentiation syndromeFAERS: 4US FAERS
77ArthropathyFAERS: 4OFFSIDES
SIDER
US FAERS
78Blood creatine phosphokinase increasedFAERS: 4OFFSIDES
US FAERS
79CataractFAERS: 4SIDER
US FAERS
80CholelithiasisFAERS: 4US FAERS
81CholestasisFAERS: 411922592
23384448
CTD
US FAERS
82CystitisFAERS: 4US FAERS
83Deep Vein ThrombosisFAERS: 4US FAERS
84Depressed moodFAERS: 4US FAERS
85DizzinessFAERS: 4SIDER
US FAERS
86Inappropriate schedule of drug administrationFAERS: 4US FAERS
87InflammationFAERS: 4US FAERS
88LymphadenopathyFAERS: 4US FAERS
89Lymphocyte count increasedFAERS: 4US FAERS
90Maternal exposure during pregnancyFAERS: 4US FAERS
91No adverse eventFAERS: 4US FAERS
92OsteopeniaFAERS: 4US FAERS
93Product availability issueFAERS: 4US FAERS
94Pulmonary FibrosisFAERS: 4US FAERS
95RhabdomyolysisFAERS: 4OFFSIDES
US FAERS
96SepsisFAERS: 4US FAERS
97Skin reactionFAERS: 4US FAERS
98Suicide attemptFAERS: 4US FAERS
99Therapy cessationFAERS: 4US FAERS
100ThirstFAERS: 4SIDER
US FAERS
101Trisomy 21FAERS: 4OFFSIDES
US FAERS
102Visual disturbanceFAERS: 4OFFSIDES
SIDER
US FAERS
103Vitamin D DeficiencyFAERS: 4US FAERS
104Vulvovaginal pruritusFAERS: 4US FAERS
105Wrong patient received medicationFAERS: 4US FAERS
106AbasiaFAERS: 3OFFSIDES
US FAERS
107AnorexiaFAERS: 3OFFSIDES
SIDER
US FAERS
108AstheniaFAERS: 3OFFSIDES
SIDER
US FAERS
109BlindnessFAERS: 3US FAERS
110Blood alkaline phosphatase increasedFAERS: 3OFFSIDES
US FAERS
111Blood glucose decreasedFAERS: 3OFFSIDES
US FAERS
112Blood glucose increasedFAERS: 3US FAERS
113Blood immunoglobulin A increasedFAERS: 3OFFSIDES
US FAERS
114Bone density decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
115Capillary Leak SyndromeFAERS: 314746632
17097361
CTD
OFFSIDES
SIDER
US FAERS
116Cerebral ThrombosisFAERS: 3OFFSIDES
US FAERS
117CheilitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
118Cytolytic hepatitisFAERS: 3OFFSIDES
US FAERS
119Deafness NeurosensoryFAERS: 3OFFSIDES
US FAERS
120Depressed Level of ConsciousnessFAERS: 3US FAERS
121Drug administered to patient of inappropriate ageFAERS: 3US FAERS
122Electromyogram abnormalFAERS: 3OFFSIDES
US FAERS
123Expired product administeredFAERS: 3US FAERS
124Exposure via body fluidFAERS: 3US FAERS
125Eyelids pruritusFAERS: 3US FAERS
126HepatitisFAERS: 3OFFSIDES
SIDER
US FAERS
127HypersensitivityFAERS: 3SIDER
US FAERS
128HypotensionFAERS: 3US FAERS
129HypoxiaFAERS: 3US FAERS
130Intentional product misuseFAERS: 3US FAERS
131Joint injuryFAERS: 3US FAERS
132Keratoconjunctivitis SiccaFAERS: 3US FAERS
133Lip swellingFAERS: 3US FAERS
134Musculoskeletal PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
135MyositisFAERS: 3US FAERS
136Nasal pruritusFAERS: 3US FAERS
137Neck PainFAERS: 3US FAERS
138NecrosisFAERS: 3US FAERS
139Oral mucosal exfoliationFAERS: 3US FAERS
140Peripheral swellingFAERS: 3US FAERS
141PolyneuropathyFAERS: 3US FAERS
142Pregnancy on contraceptiveFAERS: 3OFFSIDES
US FAERS
143Product use complaintFAERS: 3US FAERS
144PyelonephritisFAERS: 3OFFSIDES
US FAERS
145Retinal DetachmentFAERS: 3US FAERS
146Retinoic acid syndromeFAERS: 3OFFSIDES
US FAERS
147RicketsFAERS: 3US FAERS
148Stevens-Johnson SyndromeFAERS: 3OFFSIDES
US FAERS
149SwellingFAERS: 3US FAERS
150ThrombocytopeniaFAERS: 3US FAERS
151ThrombosisFAERS: 312452748CTD
US FAERS
152TinnitusFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
153Transaminases increasedFAERS: 3US FAERS
154Urinary RetentionFAERS: 3US FAERS
155Visual ImpairmentFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
156jaundiceFAERS: 3
Canada Vigilance: 1
11922592CTD
SIDER
Canada Vigilance
US FAERS
157nervous system disorderFAERS: 3US FAERS
158treatment failureFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
159Accidental overdoseFAERS: 2US FAERS
160AgitationFAERS: 2US FAERS
161AmnesiaFAERS: 2OFFSIDES
US FAERS
162AngerFAERS: 2US FAERS
163AngioedemaFAERS: 2SIDER
US FAERS
164ApathyFAERS: 2US FAERS
165AphasiaFAERS: 2US FAERS
166Bacterial test positiveFAERS: 2US FAERS
167BedriddenFAERS: 2OFFSIDES
US FAERS
168Biliary ColicFAERS: 2US FAERS
169Blood 25-hydroxycholecalciferol decreasedFAERS: 2OFFSIDES
US FAERS
170Blood urea increasedFAERS: 2US FAERS
171Bone callus excessiveFAERS: 2US FAERS
172Bone painFAERS: 2OFFSIDES
SIDER
US FAERS
173Cerebral InfarctionFAERS: 2US FAERS
174Cerebral cystFAERS: 2OFFSIDES
US FAERS
175ChokingFAERS: 2US FAERS
176CholecystitisFAERS: 2US FAERS
177Contraindicated drug prescribedFAERS: 2US FAERS
178Contraindicated product administeredFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
179Creatinine renal clearance decreasedFAERS: 2US FAERS
180DeafnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
181Disease recurrenceFAERS: 2OFFSIDES
US FAERS
182DisorientationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
183DiverticulitisFAERS: 2OFFSIDES
US FAERS
184Drug ineffective for unapproved indicationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
185DysphoniaFAERS: 216274958CTD
SIDER
US FAERS
186DysuriaFAERS: 2SIDER
US FAERS
187EctropionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
188FlushingFAERS: 2SIDER
US FAERS
189Gamma-Glutamyltransferase IncreasedFAERS: 2OFFSIDES
US FAERS
190Gingival HyperplasiaFAERS: 2SIDER
US FAERS
191Hepatitis CFAERS: 2OFFSIDES
US FAERS
192Hypertensive EncephalopathyFAERS: 2US FAERS
193Immune thrombocytopenic purpuraFAERS: 2US FAERS
194Inappropriate PrescribingFAERS: 2US FAERS
195Increased tendency to bruiseFAERS: 2US FAERS
196Inflammatory marker increasedFAERS: 2US FAERS
197Intellectual DisabilityFAERS: 2US FAERS
198Intercepted drug dispensing errorFAERS: 2US FAERS
199Joint Range of Motion DecreasedFAERS: 2US FAERS
200LacerationFAERS: 2US FAERS
201LeukopeniaFAERS: 2US FAERS
202Limb injuryFAERS: 2US FAERS
203Limb operationFAERS: 2US FAERS
204Macular degenerationFAERS: 2US FAERS
205Memory impairmentFAERS: 2US FAERS
206MicrocephalyFAERS: 215470719CTD
US FAERS
207Mouth swellingFAERS: 2US FAERS
208Musculoskeletal discomfortFAERS: 2SIDER
US FAERS
209Mycosis FungoidesFAERS: 2OFFSIDES
US FAERS
210Nail InfectionFAERS: 2OFFSIDES
US FAERS
211NervousnessFAERS: 2SIDER
US FAERS
212Nonspecific reactionFAERS: 2US FAERS
213Osteocalcin decreasedFAERS: 2OFFSIDES
US FAERS
214OsteosclerosisFAERS: 2US FAERS
215Post procedural complicationFAERS: 2US FAERS
216Product label confusionFAERS: 2US FAERS
217Product lot number issueFAERS: 2US FAERS
218Product quality issueFAERS: 2OFFSIDES
US FAERS
219Product substitution issueFAERS: 2US FAERS
220Pubic painFAERS: 2US FAERS
221Pulmonary malformationFAERS: 2OFFSIDES
US FAERS
222Rehabilitation therapyFAERS: 2US FAERS
223Single umbilical arteryFAERS: 2OFFSIDES
US FAERS
224SinusitisFAERS: 2SIDER
US FAERS
225Skin hypertrophyFAERS: 2SIDER
US FAERS
226Sperm count decreasedFAERS: 2OFFSIDES
US FAERS
227Squamous cell carcinoma of skinFAERS: 2US FAERS
228StressFAERS: 2OFFSIDES
US FAERS
229Supraventricular tachycardiaFAERS: 2OFFSIDES
US FAERS
230SyndactylyFAERS: 2OFFSIDES
US FAERS
231Therapeutic product effect incompleteFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
232Therapy non-responderFAERS: 2OFFSIDES
US FAERS
233TremorFAERS: 2US FAERS
234Urinary sediment presentFAERS: 2US FAERS
235VIIth nerve paralysisFAERS: 2US FAERS
236Vascular ruptureFAERS: 2OFFSIDES
US FAERS
237VasculitisFAERS: 2SIDER
US FAERS
238VasospasmFAERS: 2OFFSIDES
US FAERS
239Wrong technique in product usage processFAERS: 2US FAERS
240Aborted pregnancyFAERS: 1US FAERS
241AcanthomaFAERS: 1US FAERS
242Accidental exposure to productFAERS: 1US FAERS
243Accidental exposureFAERS: 1US FAERS
244Achromotrichia acquiredFAERS: 1US FAERS
245AcneFAERS: 1SIDER
US FAERS
246Acoustic stimulation tests abnormalFAERS: 1US FAERS
247Actinic keratosisFAERS: 1US FAERS
248Activities of daily living impairedFAERS: 1US FAERS
249Acute myocardial infarctionFAERS: 1OFFSIDES
SIDER
US FAERS
250Acute vestibular syndromeFAERS: 1US FAERS
251AdenocarcinomaFAERS: 1OFFSIDES
US FAERS
252Adverse eventFAERS: 1OFFSIDES
US FAERS
253AgeusiaFAERS: 1OFFSIDES
SIDER
US FAERS
254AnosmiaFAERS: 1US FAERS
255Anticoagulation drug level abnormalFAERS: 1US FAERS
256Antinuclear antibody increasedFAERS: 1US FAERS
257AphoniaFAERS: 1US FAERS
258AscitesFAERS: 1OFFSIDES
US FAERS
259AsthmaFAERS: 1US FAERS
260AzoospermiaFAERS: 1US FAERS
261Back disorderFAERS: 1US FAERS
262Bladder cancer recurrentFAERS: 1US FAERS
263Blood 1,25-dihydroxycholecalciferol decreasedFAERS: 1US FAERS
264Blood follicle stimulating hormone increasedFAERS: 1US FAERS
265Blood parathyroid hormone decreasedFAERS: 1OFFSIDES
US FAERS
266Blood parathyroid hormone increasedFAERS: 1OFFSIDES
US FAERS
267Blood potassium increasedFAERS: 1OFFSIDES
US FAERS
268Blood pressure fluctuationFAERS: 1US FAERS
269Blood urine presentFAERS: 1US FAERS
270Body temperature fluctuationFAERS: 1US FAERS
271BradycardiaFAERS: 1US FAERS
272Breech PresentationFAERS: 1US FAERS
273BronchitisFAERS: 1US FAERS
274Burning sensationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
275CalcinosisFAERS: 1OFFSIDES
US FAERS
276CellulitisFAERS: 1OFFSIDES
US FAERS
277Cerebral artery stenosisFAERS: 1US FAERS
278Cerebrovascular stenosisFAERS: 1US FAERS
279ChemotherapyFAERS: 1US FAERS
280Chest PainFAERS: 1SIDER
US FAERS
281ChillsFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
282CholangitisFAERS: 1US FAERS
283Chronic sinusitisFAERS: 1US FAERS
284Circumstance or information capable of leading to medication errorFAERS: 1OFFSIDES
US FAERS
285ColectomyFAERS: 1US FAERS
286Complications of maternal exposure to therapeutic drugsFAERS: 1US FAERS
287Corneal PerforationFAERS: 1US FAERS
288CryingFAERS: 1US FAERS
289CystFAERS: 1SIDER
US FAERS
290Decreased immune responsivenessFAERS: 1US FAERS
291DermatitisFAERS: 1SIDER
US FAERS
292Device related infectionFAERS: 1US FAERS
293Diabetic RetinopathyFAERS: 1US FAERS
294DiplopiaFAERS: 117894719CTD
SIDER
US FAERS
295DiscomfortFAERS: 1SIDER
US FAERS
296Disease ProgressionFAERS: 1US FAERS
297Disease risk factorFAERS: 1US FAERS
298Drug monitoring procedure not performedFAERS: 1US FAERS
299DyspepsiaFAERS: 1OFFSIDES
SIDER
US FAERS
300EcchymosisFAERS: 1US FAERS
301Electroencephalogram abnormalFAERS: 1US FAERS
302Emotional disorderFAERS: 1US FAERS
303EncephaloceleFAERS: 1US FAERS
304Essential TremorFAERS: 1OFFSIDES
US FAERS
305Excessive cerumen productionFAERS: 1US FAERS
306ExcoriationFAERS: 1US FAERS
307Exposure via semenFAERS: 1US FAERS
308Eye painFAERS: 1SIDER
US FAERS
309Eye prosthesis insertionFAERS: 1US FAERS
310FibromyalgiaFAERS: 1US FAERS
311Foaming at mouthFAERS: 1US FAERS
312FractureFAERS: 1US FAERS
313Gastrointestinal PainFAERS: 1SIDER
US FAERS
314GlaucomaFAERS: 1OFFSIDES
US FAERS
315Graft lossFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
316GranulomaFAERS: 1US FAERS
317Guttate psoriasisFAERS: 1US FAERS
318Hepatic congestionFAERS: 1US FAERS
319Hepatic necrosisFAERS: 1OFFSIDES
US FAERS
320HepatotoxicityFAERS: 1OFFSIDES
US FAERS
321HerniaFAERS: 1US FAERS
322HungerFAERS: 1US FAERS
323HyperkeratosisFAERS: 1OFFSIDES
SIDER
US FAERS
324HyperplasiaFAERS: 1US FAERS
325HypothyroidismFAERS: 1US FAERS
326HypotrichosisFAERS: 1US FAERS
327HysterectomyFAERS: 1US FAERS
328Hysterosalpingo-oophorectomyFAERS: 1US FAERS
329Idiosyncratic drug reactionFAERS: 1US FAERS
330Impaired work abilityFAERS: 1US FAERS
331In-stent coronary artery restenosisFAERS: 1US FAERS
332InfertilityFAERS: 1US FAERS
333InfluenzaFAERS: 1US FAERS
334Intestinal ObstructionFAERS: 1US FAERS
335KeratitisFAERS: 1US FAERS
336KeratoconusFAERS: 1US FAERS
337LethargyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
338Lipids abnormalFAERS: 1US FAERS
339Loss of personal independence in daily activitiesFAERS: 1US FAERS
340Low density lipoprotein increasedFAERS: 1US FAERS
341Lung consolidationFAERS: 1US FAERS
342MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
343Malignant melanoma in situFAERS: 1US FAERS
344Malignant neoplasm progressionFAERS: 1US FAERS
345Mastication disorderFAERS: 1US FAERS
346Maternal exposure timing unspecifiedFAERS: 1US FAERS
347MeningoceleFAERS: 1OFFSIDES
US FAERS
348Mental impairmentFAERS: 1US FAERS
349Metabolic acidosisFAERS: 1OFFSIDES
US FAERS
350MetastasisFAERS: 1US FAERS
351MicroalbuminuriaFAERS: 1OFFSIDES
US FAERS
352Monocyte count increasedFAERS: 1US FAERS
353Mood swingsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
354MoroseFAERS: 1US FAERS
355Multiple SclerosisFAERS: 1US FAERS
356MyocarditisFAERS: 1US FAERS
357MyopathyFAERS: 1SIDER
US FAERS
358Nasal mucosal disorderFAERS: 1US FAERS
359Neonatal disorderFAERS: 1US FAERS
360Neonatal pneumoniaFAERS: 1US FAERS
361NephrolithiasisFAERS: 1US FAERS
362NeuroborreliosisFAERS: 1US FAERS
363Ocular icterusFAERS: 1US FAERS
364Oncologic complicationFAERS: 1US FAERS
365OsteochondrosisFAERS: 1US FAERS
366PancytopeniaFAERS: 1SIDER
US FAERS
367Penis carcinomaFAERS: 1US FAERS
368PhlebitisFAERS: 1OFFSIDES
US FAERS
369PhotophobiaFAERS: 1SIDER
US FAERS
370PityriasisFAERS: 1US FAERS
371Poor quality sleepFAERS: 1US FAERS
372Portal HypertensionFAERS: 1US FAERS
373Portal Vein ThrombosisFAERS: 1US FAERS
374Postoperative thrombosisFAERS: 1OFFSIDES
US FAERS
375Precancerous skin lesionFAERS: 1US FAERS
376Pregnancy on oral contraceptiveFAERS: 1OFFSIDES
US FAERS
377Pregnancy test positiveFAERS: 1OFFSIDES
US FAERS
378Pregnancy with contraceptive deviceFAERS: 1US FAERS
379Premature MenopauseFAERS: 1US FAERS
380PresyncopeFAERS: 1US FAERS
381Procollagen type I C-terminal propeptide increasedFAERS: 1US FAERS
382ProctostomyFAERS: 1US FAERS
383Product preparation errorFAERS: 1US FAERS
384ProteinuriaFAERS: 1SIDER
US FAERS
385PseudarthrosisFAERS: 1US FAERS
386Pulmonary InfarctionFAERS: 1US FAERS
387Pulmonary congestionFAERS: 1US FAERS
388Pustular psoriasisFAERS: 1US FAERS
389RalesFAERS: 1US FAERS
390Rash follicularFAERS: 1US FAERS
391Respiratory FailureFAERS: 1US FAERS
392Respiratory distressFAERS: 1US FAERS
393Restrictive pulmonary diseaseFAERS: 1US FAERS
394Retinal artery embolismFAERS: 1US FAERS
395RhonchiFAERS: 1US FAERS
396RosaceaFAERS: 1US FAERS
397Salivary gland operationFAERS: 1US FAERS
398Similar reaction on previous exposure to drugFAERS: 1US FAERS
399Skin discomfortFAERS: 1US FAERS
400Skin necrosisFAERS: 1US FAERS
401Skin neoplasm excisionFAERS: 1US FAERS
402Skin toxicityFAERS: 1US FAERS
403SmokerFAERS: 1US FAERS
404Spermatozoa progressive motility decreasedFAERS: 1US FAERS
405Spinal Muscular AtrophyFAERS: 1US FAERS
406StillbirthFAERS: 1US FAERS
407Suture insertionFAERS: 1US FAERS
408Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
409TachycardiaFAERS: 1US FAERS
410TalipesFAERS: 1OFFSIDES
US FAERS
411Throat irritationFAERS: 1US FAERS
412Tongue bitingFAERS: 1US FAERS
413Tooth LossFAERS: 1US FAERS
414Traumatic Brain InjuryFAERS: 1US FAERS
415TrismusFAERS: 1US FAERS
416Unevaluable eventFAERS: 1US FAERS
417Urinary IncontinenceFAERS: 1US FAERS
418Urinary tract infectionFAERS: 1SIDER
US FAERS
419Urine calcium decreasedFAERS: 1US FAERS
420Urine calcium increasedFAERS: 1US FAERS
421Uterine CancerFAERS: 1US FAERS
422Vascular stenosisFAERS: 1US FAERS
423Venous InsufficiencyFAERS: 1US FAERS
424VertigoFAERS: 1US FAERS
425White blood cell count decreasedFAERS: 1SIDER
US FAERS
426Wound InfectionFAERS: 1US FAERS
427Wound dehiscenceFAERS: 1US FAERS
428Wound necrosisFAERS: 1US FAERS
429Wrong technique in drug usage processFAERS: 1US FAERS
430XerophthalmiaFAERS: 1SIDER
US FAERS
431colonoscopyFAERS: 1US FAERS
432Abdominal discomfortOFFSIDES
433Abducens Nerve Diseases17894719CTD
434Acitretin embryopathy15470719CTD
435Alcohol IntoleranceSIDER
436Alcohol abuseSIDER
437Alcohol consumptionOFFSIDES
438Altered bowel functionOFFSIDES
439AmputationOFFSIDES
440Androgenetic AlopeciaOFFSIDES
441Angina PectorisCanada Vigilance: 1Canada Vigilance
442AnhidrosisOFFSIDES
443Anorectal discomfortSIDER
444Antimicrobial susceptibility test resistantOFFSIDES
445Arthritis, Psoriatic14746632CTD
446Atrial FlutterOFFSIDES
447Atrophic vulvovaginitisSIDER
448BalanoposthitisSIDER
449Biliary dilatationOFFSIDES
450BlepharitisOFFSIDES
SIDER
451Blood GlucoseOFFSIDES
452Blood cholesterolOFFSIDES
453Blood magnesium decreasedOFFSIDES
454Blood potassium decreasedOFFSIDES
455Blood sodium increasedSIDER
456Bone scan abnormalOFFSIDES
457Brain Infarction12452748CTD
458Bullous eruptionSIDER
459Burning feet syndromeCanada Vigilance: 2Canada Vigilance
460BursitisSIDER
461CD4 Lymphocytes DecreasedOFFSIDES
462Carcinoma of lungSIDER
463Catheter related complicationOFFSIDES
464Catheter related infectionOFFSIDES
465Cell DeathOFFSIDES
466CeruminosisSIDER
467Chemical and Drug Induced Liver Injury2147707
23384448
24085192
CTD
468Chemical and Drug Induced Liver Injury, Chronic11922592CTD
469Chronic ulcerative colitisOFFSIDES
470Cold sweatSIDER
471Common wartSIDER
472ConfabulationOFFSIDES
473Congenital cerebral cystOFFSIDES
474Congenital heart diseaseOFFSIDES
475Conjunctival irritationOFFSIDES
476ConjunctivitisSIDER
477ConstipationSIDER
478Corneal UlcerOFFSIDES
479Cramps of lower extremitiesSIDER
480Craniofacial Abnormalities8838291CTD
481Creatinine increasedSIDER
482CyanosisOFFSIDES
SIDER
483CytopeniaSIDER
484Decreased night visionSIDER
485Decreased toleranceSIDER
486DehydrationOFFSIDES
487DiabetesOFFSIDES
488Diabetes mellitus inadequate controlOFFSIDES
489DiabeticSIDER
490Disseminated Intravascular CoagulationOFFSIDES
491Disturbance in sexual arousalSIDER
492DrowsinessOFFSIDES
493Drug resistanceOFFSIDES
494Drug toxicityOFFSIDES
495DysgeusiaSIDER
496EczemaSIDER
497Edema14746632CTD
498Electrocardiogram QT interval abnormalOFFSIDES
499EmbolismSIDER
500EnthesopathyOFFSIDES
501Eosinophilic myocarditisOFFSIDES
502EpilepsyOFFSIDES
503Erythrodermic psoriasisOFFSIDES
504Eye irritationSIDER
505FastingSIDER
506Febrile NeutropeniaSIDER
507Feeling abnormalSIDER
508Fibrosis11922592CTD
509Fluid overloadOFFSIDES
510FurunculosisSIDER
511Gallop rhythm presentOFFSIDES
512GastritisSIDER
513GastroenteritisSIDER
514GingivitisSIDER
515GlossitisOFFSIDES
SIDER
516GlycosuriaSIDER
517GranulocytosisOFFSIDES
518Grip strength decreasedCanada Vigilance: 1Canada Vigilance
519Hair discolorationSIDER
520Hearing Loss16858938CTD
521HemiparesisOFFSIDES
522Hemisensory NeglectOFFSIDES
523Hepatitis B positiveOFFSIDES
524Hepatitis FSIDER
525HordeolumSIDER
526HydrocephalusOFFSIDES
527HyperostosisSIDER
528HypertrichosisSIDER
529Hypervitaminosis ASIDER
530Hypoplastic Left Heart SyndromeOFFSIDES
531Impaired driving abilityOFFSIDES
532Impaired gastric emptyingOFFSIDES
533Influenza-like symptomsSIDER
534Infusion site mobility decreasedOFFSIDES
535Intentional self-injurySIDER
536Intermittent ClaudicationSIDER
537IritisSIDER
538Joint stiffnessCanada Vigilance: 2Canada Vigilance
539Keratitis siccaOFFSIDES
540KetonuriaSIDER
541Kidney FailureOFFSIDES
542Lacrimation abnormal NOSSIDER
543Large cell carcinoma of the respiratory tract stage unspecifiedOFFSIDES
544LaryngitisSIDER
545LeukorrheaSIDER
546Limb Deformities, Congenital8838291CTD
547Liver Cirrhosis2147707
11922592
CTD
548Lymph Node TuberculosisOFFSIDES
549LymphocytosisOFFSIDES
550Mental status changesOFFSIDES
551Monocyte count decreasedSIDER
552Multiple drug overdoseOFFSIDES
553Muscle WeaknessOFFSIDES
554Muscle necrosisOFFSIDES
555MyelodysplasiaOFFSIDES
556Nail bed infectionOFFSIDES
557NeuritisSIDER
558ObesitySIDER
559Olecranon bursitisSIDER
560Optic NeuritisSIDER
561Orthostatic hypertensionOFFSIDES
562OsteolysisOFFSIDES
563Otitis ExternaSIDER
564Otitis MediaSIDER
565OverdoseOFFSIDES
566PalpitationsCanada Vigilance: 1Canada Vigilance
567Papillon-Lefevre Disease16008657CTD
568PeriarthritisOFFSIDES
569Peripheral Nervous System Diseases11859946
12566828
CTD
570PharyngitisSIDER
571Pityriasis Rubra PilarisOFFSIDES
572PlasmacytomaOFFSIDES
573Posterior subcapsular cataractSIDER
574Postoperative ileusOFFSIDES
575Potentiating drug interactionOFFSIDES
576Pregnancy with injectable contraceptiveOFFSIDES
577PresbyopiaOFFSIDES
578Protein urine presentSIDER
579Psoriasis flare-upSIDER
580Pulmonary thrombosisOFFSIDES
581PurpuraSIDER
582PurulenceOFFSIDES
583Rash erythematousSIDER
584Rectal tenesmusSIDER
585RednessSIDER
586Renal cystOFFSIDES
587RhinitisSIDER
588RhinorrheaOFFSIDES
589Saliva alteredSIDER
590ScabSIDER
591Schizoaffective DisorderOFFSIDES
592SchizophreniaOFFSIDES
593SclerodermaSIDER
594ScotomaSIDER
595Sinus bradycardiaOFFSIDES
596Skin Neoplasms17894719CTD
597Skin PapillomaSIDER
598Skin graft infectionCanada Vigilance: 1Canada Vigilance
599Skin irritationSIDER
600Skin noduleSIDER
601Sodium highSIDER
602SomnolenceSIDER
603Spina BifidaOFFSIDES
604StomatitisSIDER
605Sudden deathOFFSIDES
606SunburnSIDER
607SyndesmophyteOFFSIDES
608SynovitisOFFSIDES
609T-Cell LymphomaOFFSIDES
610TendinitisOFFSIDES
611TensionSIDER
612ThromboembolismSIDER
613Tongue Neoplasms16196285CTD
614Tooth repairOFFSIDES
615Ulcerative stomatitisSIDER
616Ultrasound uterus abnormalCanada Vigilance: 1Canada Vigilance
617Umbilical cord vascular disorderOFFSIDES
618Vaginal DischargeSIDER
619Vascular graft complicationOFFSIDES
620Vascular purpuraSIDER
621Venous occlusionOFFSIDES
622Ventricular hypokinesiaOFFSIDES
623Ventricular hypoplasiaOFFSIDES
624Virus serology test positiveOFFSIDES
625Vitreous DetachmentOFFSIDES
626VulvovaginitisSIDER
627Weight GainOFFSIDES
628Wound infection staphylococcalOFFSIDES
629XerosisCanada Vigilance: 1Canada Vigilance
630furuncleCanada Vigilance: 1Canada Vigilance
SIDER
631melanoma16109552CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.